Antiviral Research publishes research reports, short communications, review articles and commentaries on the control of viral infections in humans and animals. Its scope encompasses:
antiviral drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action;
new or improved vaccines against viral infections of humans;
assessments of drug and vaccine safety;
evolution of drug- or vaccine-resistant viruses and the development of effective countermeasures;
identification and validation of new drug targets;
laboratory animal models of viral diseases;
pathogenesis of viral diseases and mechanisms of viral evasion of host immune responses.


We encourage the submission of manuscripts describing the activity of well-defined chemical compounds for the treatment of viral diseases of humans and vertebrate animals. We also publish manuscripts on the protective activity of vaccines for humans, but we do not accept research reports on veterinary vaccines. All papers must include a sufficiently detailed description of methods to permit other investigators to replicate the experiments. Authors reporting the antiviral effect of a novel small-molecule drug must reveal its chemical structure. Claims of in vitro or in vivo efficacy of a drug or vaccine must be supported by appropriate statistical analysis.


The scope of AVR is limited to viral diseases of humans and vertebrate animals. We do not accept reports on viral diseases of plants or of insects, crustaceans or other invertebrates. We discourage the submission of manuscripts reporting the antiviral activity of unpurified natural products, or of partially purified substances of natural origin for which a mechanism of action has not been determined. Manuscripts claiming an antiviral effect of homeopathic products or other highly diluted preparations, or which fail to clearly identify the biological ingredient or molecule responsible for the antiviral activity of an experimental therapy, will not be considered for publication. Articles describing antiseptics with broad-spectrum antimicrobial activity will not be accepted. We also discourage submission of in silico docking studies or other computer-based predictions of antiviral activity that are not supported by data from biological assays.


Antiviral Research is an official publication of the International Society for Antiviral Research (http://www.isar-icar.com). 

Research Articles
Short Communications
Review articles

Editor-in-Chief
Mike Bray
Chevy Chase, MD, USA
Advisory Editor
Johan Neyts
Leuven, Belgium
Editors
Jinhong Chang
Doylestown, Pennsylvania, United States
David Durantel
Lyon, France
José Esté
Barcelona, Spain
Nesya Goris
Leuven, Belgium
Jennifer McKimm-Breschkin
Parkville, Australia
Jennifer Moffat
Syracuse, New York, United States
Tao Peng
Guangzhou, China
Subhash Vasudevan
Singapore
Editorial Board
Yacine Abed
Quebec, Canada
Graciela Andrei
Leuven, Belgium
Masonari Baba
Kagoshima, Japan
Ester Ballana
Badalona, Spain
Sina Bavari
Frederick, Maryland, United States
John Beigel
Bethesda, Maryland, United States
Timothy Block
Doylestown, Pennsylvania, United States
David Boutolleau
Paris, France
Andrea Brancale
Cardiff, United Kingdom
Stéphane Bressanelli
Orsay, France
Rhonda Cardin
Cincinnati, Ohio, United States
Ling Chen
Beijing, China
Guofeng Cheng
Foster City, California, United States
Sunwen Chou
Portland, Oregon, United States
Zeger Debyser
Leuven, Belgium
Leen Delang
Leuven, Belgium
Jerome Deval
South San Francisco, California, United States
Edward Gershburg
Springfield, Illinois, United States
Brian Gilbert
Houston, Texas, United States
Elena Govorkova
Memphis, Tennessee, United States
Brian Gowen
Logan, Utah, United States
Haitao Guo
Indianapolis, Indiana, United States
Ju-Tao Guo
Doylestown, Pennsylvania, United States
Amy L. Hartman
Pittsburgh, Pennsylvania, United States
Uzma Hasan
Paris, France
Rolf Hilgenfeld
Lubeck, Germany
Jim-Tong Horng
Taoyuan, Taiwan
David Hui
Hong Kong, Hong Kong
Aeron Hurt
North Melbourne, Victoria, Australia
Natalia Ilyushina
White Oak, Maryland, USA
Shibo Jiang
Shanghai, China
Colleen Jonsson
Louisville, Kentucky, United States
Robert Jordan
Foster City, California, United States
Justin Julander
Logan, Utah, United States
Kylene Kehn-Hall
Fairfax, Virginia, United States
Thomas Keller
Singapore
Gloria Komazin-Meredith
University Park, Pennsylvania, United States
Takeshi Kurosu
Shinjuku-Ku, Japan
Randall Lanier
Durham, North Carolina, United States
Hakan Leblebicioglu
Samsun, Turkey
Julien Lescar
Singapore
Yuhuan Li
Beijing, China
Siew Pheng Lim
Singapore
Jenny Low
Singapore, Singapore
Stephan Ludwig
Munster, Germany
Dahai Luo
Singapore, Singapore
Miguel Angel Martinez
Barcelona, Spain
Luis Menendez- Arias
Madrid, Spain
Carmen Mirabelli
Ann Arbor, Michigan, United States
Jennifer Moffat
Syracuse, New York, United States
Lieve Naesens
Leuven, Belgium
Xiao-Ben Pan
Hangzhou, China
Anna Papa
Thessaloniki, Greece
Eve-Isabelle Pécheur
Lyon, France
Daniel Pevear
Malvern, Pennsylvania, United States
Jocelyne Piret
Quebec, Quebec, Canada
Oliver Planz
Tübingen, Germany
Miguel Quiñones-Mateu
Cleveland, Ohio, United States
Daniel Ruzek
Brno, Czech Republic
Luis Schang
Edmonton, Alberta, Canada
Pei-Yong Shi
Galveston, Texas, United States
Sujan Shresta
La Jolla, California, United States
Jessica Spengler
Atlanta, Georgia, United States
Christina Spiropoulou
Atlanta, Georgia, United States
Eike Steinmann
Braunschweig, Germany
Youichi Suzuki
Takatsuki, Japan
Bart Tarbet
Logan, Utah, United States
John Tavis
Saint Louis, Missouri, United States
Evelien Vanderlinden
Heverlee, Belgium
Robert Vrancken
Leuven, Belgium
Satoru Watanabe
Singapore, Singapore
Priscilla Yang
Boston, Massachusetts, United States
Hui-Ling Yen
Pokfulam, Hong Kong
Zheng Yin
Nankai, China
Bo Zhang
Wuhan, China
Jin Zhong
Shanghai, China
Gang Zou
Shanghai, China